[ RadSafe ] Disruption of medical isotope supply
Christopher W. Becker
cwbecker at umich.edu
Thu Dec 6 10:34:44 CST 2007
I usually don't chime in to these BUT. There are a limited number of
"higher" power research and test reactors (NRC verbiage for non-power
producing reactors) in the United States.
Massachusetts Institute of Technology
University of Missouri - Columbia
National Institute of Standards and Technology - Gaithersburg
High Flux Isotope Reactor - Oak Ridge (DOE)
Idaho National Laboratory - Idaho (DOE)
Sandia National Laboratory - New Mexico (DOE)
Although, one or two of them generate isotopes in some areas, I am not aware
of any of them pursuing Molly-99 for a variety of reasons (technical and
financial). The lack of a second source should have been a known issue for
years. I am mused at how surprised many have been that there IS only one
source. If you are waiting for DOE or the federal government to ride in and
save the day.........
Now Nordian has been making plans for a new reactor to supply this and other
materials.....but there are some big problems with the design (can you say
positive reactivity feeback).
So........if you were surprised this time......
Christopher W. Becker
We just got word that MDS Nordion is having supply problems. Does anyone
have information about what alternate sources of medical isotopes may be
available and whether they will be able to make up the shortfall? (I
think I know the answers, but I'm hoping someone has better information than
A potion of Nordion's update to its customers is attached.
Ottawa, Canada, December 5, 2007 - MDS Nordion, a leading provider
of medical isotopes and radiopharmaceuticals, has provided a
further update to their medical isotope customers about a supply
issue at Atomic Energy of Canada Limited (AECL) that is now
expected to extend into January 2008. AECL has advised MDS Nordion
that a further extension of the maintenance shutdown at the
National Research Universal reactor will be required to complete
its upgrade of the electrical back-up system to address a
AECL is working closely with their regulator, the Canadian Nuclear
Safety Commission, to finalize and complete implementation of their
upgrade plan. Based on the most current information from AECL, we
understand that they are now targeting a return to full production
in early to mid-January.
MDS Nordion is concerned with the impact that AECL's supply
disruption is having on customers and patients. As the global
leader in the supply of medical isotopes, MDS Nordion is working
closely with its back-up supply network to mitigate the impact. ...
IMPORTANT NOTICE: This e-mail and any attachments may contain confidential
or sensitive information which is, or may be, legally privileged or
otherwise protected by law from further disclosure. It is intended only for
the addressee. If you received this in error or from someone who was not
authorized to send it to you, please do not distribute, copy or use it or
any attachments. Please notify the sender immediately by reply e-mail and
delete this from your system. Thank you for your cooperation.
More information about the RadSafe